Source:http://linkedlifedata.com/resource/pubmed/id/16117800
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2005-8-24
|
pubmed:abstractText |
Topical application of dibenzo[a,l]pyrene (DB[a,l]P) to the dorsal skin of SENCAR mice induces codon 61 (CAA Gln to CTA Leu) mutations in the Harvey (H)-ras gene within 12 h after treatment. Between days 1 and 3, the frequency of these mutations increases rapidly, suggesting that skin cells carrying the codon 61 mutations proliferate in this period. We have investigated DB[a,l]P-treated mouse skin (12 h-7 d) for further evidence of H-ras expression and epidermal cell proliferation. Two waves of cell proliferation were observed: the first wave (1-2 d) correlated with the clonal proliferation of codon 61-mutated cells, and the second wave (3-7 d) correlated with DB[a,l]P-induced hyperplasia. DB[a,l]P-induced early preneoplastic cell proliferation correlated with H-ras and specific G1 cyclin expression. Total H-ras protein and cyclin D1 were found to increase during DB[a,l]P-induced hyperplasia, but the levels of guanosine triphosphate-bound (active) H-ras protein and cyclin E were increased during the putative clonal proliferation of codon 61-mutated cells. These results suggest that DB[a,l]P-induced oncogenically mutated cells proliferate in early preneoplastic skin. As this proliferation occurs in the absence of any promoting treatment, we propose that this phenomenon is a tumor initiation event.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Benzopyrenes,
http://linkedlifedata.com/resource/pubmed/chemical/Ccng1 protein, mouse,
http://linkedlifedata.com/resource/pubmed/chemical/Cyclin G,
http://linkedlifedata.com/resource/pubmed/chemical/Cyclin G1,
http://linkedlifedata.com/resource/pubmed/chemical/Cyclins,
http://linkedlifedata.com/resource/pubmed/chemical/dibenzo(a,l)pyrene,
http://linkedlifedata.com/resource/pubmed/chemical/ras Proteins
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0022-202X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
125
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
567-74
|
pubmed:dateRevised |
2009-11-19
|
pubmed:meshHeading |
pubmed-meshheading:16117800-Animals,
pubmed-meshheading:16117800-Benzopyrenes,
pubmed-meshheading:16117800-Cell Proliferation,
pubmed-meshheading:16117800-Cyclin G,
pubmed-meshheading:16117800-Cyclin G1,
pubmed-meshheading:16117800-Cyclins,
pubmed-meshheading:16117800-Epidermis,
pubmed-meshheading:16117800-Female,
pubmed-meshheading:16117800-Gene Expression,
pubmed-meshheading:16117800-Genes, ras,
pubmed-meshheading:16117800-Mice,
pubmed-meshheading:16117800-Mice, Inbred SENCAR,
pubmed-meshheading:16117800-Mutation,
pubmed-meshheading:16117800-Precancerous Conditions,
pubmed-meshheading:16117800-Skin Neoplasms,
pubmed-meshheading:16117800-ras Proteins
|
pubmed:year |
2005
|
pubmed:articleTitle |
Harvey-ras gene expression and epidermal cell proliferation in dibenzo[a,l]pyrene-treated early preneoplastic SENCAR mouse skin.
|
pubmed:affiliation |
Eppley Institute for Research in Cancer and Allied Diseases, Nebraska Medical Center, Omaha, Nebraska 68198-6805, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, N.I.H., Extramural
|